Clinical Trial

Impact of Adding Integrated Neuromuscular Inhibition Technique to Mulligan Therapy in Symptomatic Forward Head Posture

Study acronym: FHP
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 25, 2025 (before its estimated February 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
this study will be conducted to investigate the impact of adding integrated neuromuscular inhibition technique to mulligan therapy in symptomatic forward head posture.
Trial Details
NCT Number NCT07086872
Lead Sponsor Cairo University
Conditions Forward Head Posture
Enrollment 120 participants
Start Date 2025-07-30
Primary Completion 2026-02-20 (estimated)
Study Completion 2026-02-20 (estimated)
Updated on ClinicalTrials.gov 2025-07-25